In this episode, we hear from our guest: Michelle Longmire, CEO & Co-Founder at Medable. Topics discussed: Michelle Longmire's Inspiration: In medical school, Longmire recognized a critical access gap in healthcare. Training at the University of New Mexico, she observed the challenges faced by underserved patients and envisioned a technological bridge to healthcare.Formation of Medable: The idea of Medable was shaped by Longmire's experience at Stanford and the rise of mobile technology....

In this episode, we hear from our guest: Travis Caudill, VP, Feasibility & Clinical Informatics at ICON. Topics discussed: Travis Caudill shares his journey from a health insurance company to becoming an expert in data migration and feasibility in clinical trials.The evolution of clinical trial data: Travis emphasizes how the industry has dramatically advanced from manual data entry to leveraging sophisticated AI for better decision-making.AI's transformative impact in 2023 and beyond:...

In this episode, guests Craig Lipset, Founder at Clinical Innovation Partners, and Angela Radcliffe, Founder at How We Mighty Ventures, discuss AI's transformative role in clinical trials. Topics discsued: • The potential and challenges of AI in healthcare. • Strategies for integrating AI in clinical trial processes. • The balance between technological innovation and patient-centric approaches. • Expert Insights: In-depth analysis from leaders in the healthcare and technology sectors. •...

Today’s discussion led by guest host Anatoly Geyfman is with Omar Khateeb, Founder at Khateeb & Co to cover his MedTech year in review.

Today’s discussion led by guest host Nasreen Arain is with faculty from Faculty Opinions sharing why peer-reviewed research is not only important but critical to the future of another global health crisis.

In this episode, Chris Madeiros, Director of Strategy & Solutions at H1 and Nayanica Banerjee, Senior Manager of Client Solutions & Strategy at H1 join to discuss the intersection of KOLs and DOLs while talking about research and medical affairs.

In this episode, Brad Hightower, CEO at Hightower Clinical, and Darshan Kulkarni, Regulatory and Compliance Attorney for the Life Sciences at The Kulkarni Law Firm join to discuss the 2022 Pharma Year in Review.

In this episode, Meredith Dees, VP of Product at Lokavant & Todd Johnson, VP of Customer Success at Lokavant join to talk about big data, health equity, & the future of clinical trials.

In this episode Jocelyn Levin, Senior Customer Success Manager at H1 joins to discuss her thoughts on customer support & success for Pharma and Life Science companies.

In this episode Stacey Rivkin, Vice President of Client Solutions & Strategy at H1 joins to discuss Uncut GEMS: how treatment leaders with revolutionize Pharma and where to find them.

In this episode Ariel Katz, Co-Founder & CEO at H1 joins to discuss how AI can transform the way Pharma engages thought leaders.

In this episode Alexandra Moens, Director of Product Marketing and Adam Wyckoff, Director of Product, Clinical Trials, at H1 join to discuss Divergent Diversity: Where the world is headed with health equity and diversity in clinical trials and bringing drugs to market.

In this episode Robert Consalvo, Senior Director of Sales Engineering & Enablement at H1 joins as a guest to talk about the next best action for Pharma’s Future and Medical Affairs.

In this episode Anatoly Geyfman, VP of Medical Devices at H1 joins as a guest.

In this episode, Ariel Katz, CEO & Co-Founder at H1 joins as a guest.